Putnam Investments’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.54M Buy
37,560
+1,021
+3% +$62.5K ﹤0.01% 702
2023
Q3
$2.65M Buy
36,539
+1,290
+4% +$103K ﹤0.01% 666
2023
Q2
$2.62M Sell
35,249
-44,793
-56% -$2.65M ﹤0.01% 687
2023
Q1
$4.26M Buy
80,042
+17,328
+28% +$1.1M 0.01% 473
2022
Q4
$4.24M Buy
62,714
+18,868
+43% +$1.74M 0.01% 480
2022
Q3
$5.47M Buy
43,846
+26,694
+156% +$3.18M 0.01% 405
2022
Q2
$1.63M Buy
17,152
+253
+1% +$30.9K ﹤0.01% 791
2022
Q1
$2.72M Sell
16,899
-2,812
-14% -$547K ﹤0.01% 739
2021
Q4
$6.55M Sell
19,711
-21,460
-52% -$10.2M 0.01% 472
2021
Q3
$19.1M Buy
+41,171
New +$20M 0.03% 249

Other funds holding DNA